HI
ESPR icon

Harbour Investments’s Esperion Therapeutics ESPR Stock Holding History

Harbour Investments’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$381 Buy
139
+100
+256% +$317 ﹤0.01% 4305
2025
Q4 		$144 Hold
39
– – ﹤0.01% 3711
2025
Q3 		$103 Hold
39
– – ﹤0.01% 3639
2025
Q2 		$38 Hold
39
– – ﹤0.01% 3560
2025
Q1 		$56 Hold
39
– – ﹤0.01% 3495
2024
Q4 		$86 Hold
39
– – ﹤0.01% 3413
2024
Q3 		$64 Hold
39
– – ﹤0.01% 3337
2024
Q2 		$87 Buy
+39
New +$92 ﹤0.01% 3217
2023
Q4 		– Sell
-7
Closed -$7 – 3144
2023
Q3 		$7 Hold
7
– – ﹤0.01% 2980
2023
Q2 		$10 Hold
7
– – ﹤0.01% 3012
2023
Q1 		$11 Hold
7
– – ﹤0.01% 2981
2022
Q4 		$44 Buy
+7
New +$50 ﹤0.01% 2962
2021
Q4 		$0 Sell
76
-100
-57% -$801 ﹤0.01% 2950
2021
Q3 		$2K Hold
176
– – ﹤0.01% 3295
2021
Q2 		$4K Buy
176
+100
+132% +$2.41K ﹤0.01% 3133
2021
Q1 		$2K Buy
+76
New +$2.24K ﹤0.01% 3208

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return